---
pmid: '26493107'
title: miRNA-34a reduces neointima formation through inhibiting smooth muscle cell
  proliferation and migration.
authors:
- Chen Q
- Yang F
- Guo M
- Wen G
- Zhang C
- Luong le A
- Zhu J
- Xiao Q
- Zhang L
journal: J Mol Cell Cardiol
year: '2015'
full_text_available: false
doi: 10.1016/j.yjmcc.2015.10.017
---

# miRNA-34a reduces neointima formation through inhibiting smooth muscle cell proliferation and migration.
**Authors:** Chen Q, Yang F, Guo M, Wen G, Zhang C, Luong le A, Zhu J, Xiao Q, Zhang L
**Journal:** J Mol Cell Cardiol (2015)
**DOI:** [10.1016/j.yjmcc.2015.10.017](https://doi.org/10.1016/j.yjmcc.2015.10.017)

## Abstract

1. J Mol Cell Cardiol. 2015 Dec;89(Pt A):75-86. doi: 10.1016/j.yjmcc.2015.10.017.
 Epub 2015 Oct 19.

miRNA-34a reduces neointima formation through inhibiting smooth muscle cell 
proliferation and migration.

Chen Q(1), Yang F(1), Guo M(1), Wen G(2), Zhang C(2), Luong le A(2), Zhu J(3), 
Xiao Q(2), Zhang L(4).

Author information:
(1)Department of Cardiology, The First Affiliated Hospital, School of Medicine, 
Zhejiang University, 79 Qingchun Road, Hangzhou 310003, Zhejiang, China.
(2)Centre for Clinical Pharmacology, William Harvey Research Institute, Barts 
and The London School of Medicine and Dentistry, Queen Mary University of 
London, London EC1M 6BQ, UK.
(3)Department of Cardiology, The First Affiliated Hospital, School of Medicine, 
Zhejiang University, 79 Qingchun Road, Hangzhou 310003, Zhejiang, China. 
Electronic address: zjh_john@medmail.com.cn.
(4)Department of Cardiology, The First Affiliated Hospital, School of Medicine, 
Zhejiang University, 79 Qingchun Road, Hangzhou 310003, Zhejiang, China. 
Electronic address: li_zhang@zju.edu.cn.

AIMS: We have recently reported that microRNA-34a (miR-34a) regulates vascular 
smooth muscle cell (VSMC) differentiation from stem cells in vitro and in vivo. 
However, little is known about the functional involvements of miR-34a in VSMC 
functions and vessel injury-induced neointima formation. In the current study, 
we aimed to establish the causal role of miR-34a and its target genes in VSMC 
proliferation, migration and neointima lesion formation.
METHODS AND RESULTS: Various pathological stimuli regulate miR-34a expression in 
VSMCs through a transcriptional mechanism, and the P53 binding site is required 
for miR-34a gene regulation by these stimuli. miR-34a over-expression in 
serum-starved VSMCs significantly inhibited VSMC proliferation and migration, 
while knockdown of miR-34a dramatically promoted VSMC proliferation and 
migration, respectively. Notch homolog 1 (Notch1), a well-reported regulator in 
VSMC functions and arterial remodeling, was predicted as one of the top targets 
of miR-34a by using several computational miRNA target prediction tools, and was 
negatively regulated by miR-34a in VSMCs. Luciferase assay showed miR-34a 
substantially repressed wild type Notch1-3'-UTR-luciferase activity in VSMCs, 
but not mutant Notch1-3'-UTR-luciferease reporter, confirming the Notch1 is the 
functional target of miR-34a in VSMCs. Data from co-transfection experiments 
also revealed that miR-34a inhibited VSMC proliferation and migration through 
modulating Notch gene expression levels. Importantly, the expression level of 
miR-34a was significantly down-regulated in injured arteries, and miR-34a 
perivascular over-expression significantly reduced Notch1 expression levels, 
decreased VSMC proliferation, and inhibited neointima formation in wire-injured 
femoral arteries.
CONCLUSION: Our data have demonstrated that miR-34a is an important regulator in 
VSMC functions and neointima hyperplasia, suggesting its potential therapeutic 
application for vascular diseases.

Copyright Â© 2015 Elsevier Ltd. All rights reserved.

DOI: 10.1016/j.yjmcc.2015.10.017
PMID: 26493107 [Indexed for MEDLINE]
